AstraZeneca has made a non-binding offer of about $10 billion for Rhythm Pharmaceuticals, Reuters reports. Rhythm’s latest results show the attraction of its rare-obesity franchise, but milestone payments complicate the headline price.
Pakistan's economy posted a nine-year low of 3.3% GDP growth in fiscal 2018-19 as its rupee fell over 20% against the dollar and inflation surged. With FATF blacklisting looming over its terrorist
Israel's BIGITech tech index rose 25% in 2019 as Israeli technology firms hit record highs. A new platform, The Jerusalem Portfolio, now allows global investors to hold fractional stakes in over 100
Follow